Aprotinin and renal dysfunction after pediatric cardiac surgery

Paediatric Anaesthesia

Volumn 18, Issue 2, 2008, Pages 151-159

  Székely, Andrea ^a,c   SÁpi, Erzsébet ^a   Breuer, Tamás ^b   Kertai, Miklós D ^b   Bodor, Gábor ^a   Vargha, Péter ^b   SzatmÁri, András ^a  

^a National Institute of Cardiology Budapest   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Hungarian Institute of Cardiology   (Hungary)

Author keywords

Aprotinin; Congenital heart disease; Congenital heart surgery; Dialysis; Pediatric cardiac surgery; Pediatrics; Predictors; Renal function; Risk factors; Transfusion

Indexed keywords

APROTININ; FENTANYL; INOTROPIC AGENT; ISOFLURANE; MIDAZOLAM; PANCURONIUM; PROPOFOL; SEVOFLURANE;

ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CREATININE CLEARANCE; DIALYSIS; DRUG SAFETY; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; PEDIATRIC ANESTHESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL ANALYSIS;

APROTININ; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGICAL PROCEDURES; CHILD, PRESCHOOL; HEMOSTATICS; HUMANS; INFANT; KIDNEY FAILURE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 37749042740     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02398.x     Document Type: Article

References (34)

1. Wiliams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999 89 : 57 64.
2. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004 128 : 442 448.
3. Cosgrove DM 3rd., Heric B, Lytle BW et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992 54 : 1031 1036.
4. Bidstrup BP, Harrison J, Royston D et al. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993 55 : 971 976.
5. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006 354 : 353 365.
6. Karkouti K, Beattie WS, Dattilo KM et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006 46 : 327 338.
7. Arnold DM, Fergusson DA, Chan AK et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006 102 : 731 737.
8. Wippermann CF, Schmid FX, Eberle B et al. Reduced inotropic support after aprotinin therapy during pediatric cardiac operations. Ann Thorac Surg 1999 67 : 173 176.
9. Mossinger H, Dietrich W, Braun SL et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003 75 : 430 437.
10. Hogg RJ, Furth S, Lemley KV et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003 111 : 1416 1421.
11. Székely A, Sápi E, Király L et al. Intraoperative and postoperative risk factors for prolonged mechanical ventilation after pediatric cardiac surgery. Pediatr Anesth 2006 16 : 1166 1175.
12. Jenkins KJ. Risk adjustment for congenital heart surgery: the RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004 7 : 180 184.
13. Wernovsky G, Wypij D, Jonas RA et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995 92 : 2226 2235.
14. Shih CY, Sapru A, Oishi P et al. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 2006 131 : 632 638.
15. Schwartz GJ, Haycock GB, Edelmann CM et al. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. Pediatrics 1985 106 : 522 526.
16. Akcan-Arikan A, Zappitelli M, Loftis LL et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007 71 : 1028 1035.
17. Cooper WA, O'Brien SM, Thourani VH et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006 113 : 1063 1070.
18. Lema G, Vogel A, Canessa R et al. Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients. Pediatr Nephrol 2006 21 : 1446 1451.
19. Dittrich S, Priesemann M, Fischer T et al. Circulatory arrest and renal function in open-heart surgery on infants. Pediatr Cardiol 2002 23 : 15 19.
20. Inatomi J, Matsuoka K, Fujimaru R et al. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 2006 21 : 1440 1445.
21. Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004 15 : 1597 1605.
22. Kauker ML, Nasjletti A. Segmental nephron function in rats treated with aprotinin, an inhibitor of kallikrein. J Pharmacol Exp Ther 1986 238 : 155 158.
23. Kramer HJ, Dusing R, Glanzer K et al. Effects of aprotinin on renal function. Contrib Nephrol 1984 42 : 233 241.
24. Lemmer JH Jr., Stanford W, Bonney SL et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. Ann Thorac Surg 1995 59 : 132 136.
25. Seto S, Kher V, Scicli AG et al. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release. Hypertension 1983 5 : 893 899.
26. Skippen PW, Krahn GE. Acute renal failure in children undergoing cardiopulmonary bypass. Crit Care Resusc 2005 7 : 286 291.
27. Hoffman TM, Wernovsky G, Atz AM et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003 107 : 996 1002.
28. Brown KL, Ridout DA, Goldman AP et al. Risk factors for long intensive care unit stay after cardiopulmonary bypass in children. Crit Care Med 2003 31 : 28 33.
29. Kwiatkowski JL, Manno CS. Blood transfusion support in pediatric cardiovascular surgery. Transfus Sci 1999 21 : 63 72.
30. Royston D, Bidstrup BP, Taylor KM et al. Effect of aprotinin on the need for blood transfusion after repeat open heart surgery. Lancet 1987 2 : 1289 1291.
31. Mora Mangano CT, Neville MJ, Hsu PH et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation 2001 104 : I276 I281.
32. Ehrlich M, Grabenwoger M, Cartes-Zumelzu F et al. Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe? J Thorac Cardiovasc Surg 1998 115 : 220 225.
33. Royston D, Levy JH, Fitch J et al. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Anesth Analg 2006 103 : 1082 1088.
34. Foster EM. Propensity score matching: an illustrative analysis of dose response. Med Care 2003 41 : 1183 1192.